Impact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) study

This publication has 27 references indexed in Scilit:

• Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
  New England Journal of Medicine, 2013
• Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings
  Annals of Oncology, 2013
• Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials
  European Journal of Cancer, 2012
• Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
  Nature, 2012
• FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer–subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306
  Annals of Oncology, 2012
• Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
  Journal of Clinical Oncology, 2011
• Stem cell property epithelial‐to‐mesenchymal transition is a core transcriptional network for predicting cetuximab (Erbitux™) efficacy in KRAS wild‐type tumor cells
  Journal of Cellular Biochemistry, 2010
• The Clinical Benefit of Bevacizumab in Metastatic Colorectal Cancer Is Independent of K-ras Mutation Status: Analysis of a Phase III Study of Bevacizumab with Chemotherapy in Previously Untreated Metastatic Colorectal Cancer
  The Oncologist, 2009
• Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
  Journal of Clinical Oncology, 2008
• EGFR Antagonists in Cancer Treatment
  New England Journal of Medicine, 2008